Mark,
I'm with you! The study is more than a year old..lots can change in a year...but besides that...the study only focused on one radiation enhancing drug. What about the others? Moreover, I would think a 6% reduction in recurrence and a 6% increase in survivial is incrediably significant to those who fall into those groups. Given the option for an additional "insignificant" 6% chance of survival I think I prefer to decide what my standard treatment would be. Of course, I say this not having gone through this myself but faced with the fight I'd pull out all the weapons.

Also note that this was a press release and the full study review might give more information.